Antithrombotic therapy in atrial fibrillation.
Laupacis
A
A
Clinical Epidemiology Unit, Ottawa Hospital, Civic Campus, ON, Canada.
Albers
G
G
Dalen
J
J
Dunn
M I
MI
Jacobson
A K
AK
Singer
D E
DE
D001241:Aspirin / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications* / Q000628:therapy; D002543:Cerebral Hemorrhage / Q000139:chemically induced; D002561:Cerebrovascular Disorders / Q000209:etiology / Q000517:prevention & control*; D004554:Electric Countershock; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D012307:Risk Factors; D014859:Warfarin / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D014859:Warfarin; D001241:Aspirin